Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period (2019-2032), Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo
The Growth of the small-cell lung cancer market is expected to be driven by increasing incident cases of SCLC, mainly due to an increase in the geriatric population, the expected entry of potential premium price emerging
Clovis Oncology (NASDAQ:CLVSQ) Versus Oncotelic Therapeutics (OTCMKTS:OTLC) Head-To-Head Contrast
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) and Oncotelic Therapeutics (OTCMKTS:OTLC – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two co
Clovis Oncology (CLVSQ) & Its Peers Head to Head Survey
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) is one of 981 public companies in the "Pharmaceutical preparations" industry, but how does it contrast to its competitors? We will compare Clovis Oncology t
Financial Contrast: Clovis Oncology (CLVSQ) Versus Its Competitors
Clovis Oncology (NASDAQ:CLVSQ – Get Rating) is one of 981 public companies in the "Pharmaceutical preparations" industry, but how does it weigh in compared to its competitors? We will compare Clovis O
Clovis Oncology (NASDAQ:CLVS) Research Coverage Started at StockNews.com
Equities research analysts at StockNews.com initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research report issued on Thursday. The brokerage set a "hold" rating on th
Clovis Oncology (NASDAQ:CLVS) Earns Hold Rating From Analysts at StockNews.com
StockNews.com initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research note issued to investors on Tuesday. The firm issued a hold rating on the biopharmaceutical comp
Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S From The Nasdaq Stock Market
NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, unit, and warrant of Tuscan Holdings Corp. II. Tuscan Holdings Corp. II's securities were
Clovis Oncology (NASDAQ:CLVS) Now Covered by StockNews.com
StockNews.com began coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research report sent to investors on Monday. The firm issued a hold rating on the biopharmaceutical company's
Zacks.com Featured Highlights Include Clovis Oncology, NiSource, DocuSign, Root and Endava
News On Clovis Oncology Inc. (CLVS) Now Under CLVSQ
News On Clovis Oncology Inc. (CLVS) Now Under CLVSQ
StockNews.com Initiates Coverage on Clovis Oncology (NASDAQ:CLVS)
Analysts at StockNews.com began coverage on shares of Clovis Oncology (NASDAQ:CLVS – Get Rating) in a research note issued to investors on Monday. The firm set a "hold" rating on the biopharmaceutica
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersPLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday's after-market session. The market value of their outstanding shares is at $6.5 million. Clovis Oncology (NASDAQ:CLVS
Stocks That Hit 52-Week Lows On Wednesday
 On Wednesday, 115 stocks hit new 52-week lows. Noteable 52-Week Lows: The largest company by market cap to hit a new 52-week low was Petrobras Brasileiro (NYSE:PBR).Quotient (NASDAQ:QTNT) was the
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.Crown ElectroKinetics C
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 49 companies hit new 52-week lows. Key Facts About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) is the largest company in terms of market cap to set a new 52-week low this morning.The sma
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersOpGen (NASDAQ:OPGN) stock increased by 242.3% to $0.43 during Tuesday's regular session. OpGen's stock is trading at a volume of 169.2 million shares as of 12:30 EST. This is 40400.7% of its av
Novartis Bids $681 Million To Buy Cancer Drug From Bankruptcy Filer Clovis Oncology
10:26 PM EST, 12/12/2022 (MT Newswires) -- A Novartis (NOVN.SW) unit offered up to $680.8 million to buy Clovis Oncology's experimental cancer drug as the latter filed for bankruptcy in the US on Mond
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis -- WSJ
By Jonathan Randles Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer ther
Stocks That Hit 52-Week Lows On Monday
 Monday saw 196 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was Brookfield Asset Mgmt (NYSE:BAM
Cancer Focused Clovis Oncology Files For Bankruptcy
Clovis Oncology Inc (NASDAQ:CLVS) has voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.The Debtors h
No Data